Mitochondrial dysfunction and critical illness myopathy

Intensive Care Medicine: Annual Update 2006

Volumn , Issue , 2007, Pages 79-87

  Kothmann, E ^a   Baudouin, S V ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892221876     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-35096-9_8     Document Type: Chapter

References (33)

1. Bolton CF (1996) Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 24:1408-1416
2. Latronico N, Peli E, Botteri M (2005) Critical illness myopathy and neuropathy. Curr Opin Crit Care 11:126-132
3. De Jonghe B, Cook D, Sharshar T, Lefaucheur JP, Carlet J, Outin H (1998) Acquired neuromuscular disorders in critically ill patients: a systematic review. Groupe de Reflexion et d'Etude sur les Neuromyopathies En Reanimation. Intensive Care Med 24:1242-1250
4. Latronico N, Candiani A (1998) Muscular wasting as a consequence of sepsis. In: Gullo A (ed) Apice 1998: Anaesthesia, Pain, Intensive Care and Emergency Medicine. Springer-Ver-lag, Milan, pp 517-524
5. Gutmann L (1999) Critical illness neuropathy and myopathy. Arch Neurol 56:527-528
6. Herridge MS, Cheung AM, Tansey CM, et al (2003) One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 348:683-693
7. Fletcher SN, Kennedy DD, Ghosh IR, et al (2003) Persistent neuromuscular and neurophy-siologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med 31:1012-1016
8. Smeitink J, van den Heuvel L, DiMauro S (2001) The genetics and pathology of oxidative phosphorylation. Nat Rev Genet 2:342-352
9. Baldwin KM, Haddad F (2002) Skeletal muscle plasticity: cellular and molecular responses to altered physical activity paradigms. Am J Phys Med Rehabil 81:S40-51
10. Fluck M, Hoppeler H (2003) Molecular basis of skeletal muscle plasticity-from gene to form and function. Rev Physiol Biochem Pharmacol 146:159-216
11. Bednarik J, Lukas Z, Vondracek P (2003) Critical illness polyneuromyopathy: the electrophysiological components of a complex entity. Intensive Care Med 29:1505-1514
12. Stibler H, Edstrom L, Ahlbeck K, Remahl S, Ansved T (2003) Electrophoretic determination of the myosin/actin ratio in the diagnosis of critical illness myopathy. Intensive Care Med 29:1515-1527
13. Helhwell TR, Wilkinson A, Griffiths RD, McClelland P, Palmer TE, Bone JM (1998) Muscle fibre atrophy in critically ill patients is associated with the loss of myosin filaments and the presence of lysosomal enzymes and ubiquitin. Neuropathol Appl Neurobiol 24:507-517
14. Berek K, Margreiter J, Willeit J (1996) Polyneuropathies in critically ill patients: a propspec-tive evaluation. Intensive Care Med 22:849-855
15. de Letter MA, Schmitz PI, Visser LH, et al (2001) Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 29:2281-2286
16. Bercker S, Weber-Carstens S, Deia M, et al (2005) Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome. Crit Care Med 33:711-715
17. Owczarek J, Jasinska M, Orszulak-Michalak D (2005) Drug-induced myopathies. An overview of the possible mechanisms. Pharmacol Rep 57:23-34
18. Rich MM, Pinter MJ (2003) Crucial role of sodium channel fast inactivation in muscle fibre inexcitabihty in a rat model of critical illness myopathy. J Physiol 547:555-566
19. Van den Berghe G (2004) How does blood glucose control with insulin save lives in intensive care? J Clin Invest 114:1187-1195
20. Chinnery PF, Turnbull DM (1999) Mitochondrial DNA and disease. Lancet 354 Suppl 1: SI17-21
21. Chinnery PF, Schon EA (2003) Mitochondria. J Neurol Neurosurg Psychiatry 74:1188-1199
22. Singer M, De Santis V, Vitale D, Jeffcoate W (2004) Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 364: 545-548
23. Nair KS (2005) Aging muscle. Am J Clin Nutr 81:953-963
24. Singer M, Brealey D (1999) Mitochondrial dysfunction in sepsis. Biochem Soc Symp 66: 149-166
25. Brealey D, Brand M, Hargreaves I, et al (2002) Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360:219-223
26. Hoppeler H, Vogt M, Weibel ER, Fluck M (2003) Response of skeletal muscle mitochondria to hypoxia. Exp Physiol 88:109-119
27. Baria G (2004) Free radicals and aging. Trends Neurosci 27:595-600
28. Vanhorebeek I, De Vos R, Mesotten D, Wouters PJ, De Wolf-Peeters C, Van den Berghe G (2005) Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 365:53-59
29. Booth FW, Chakravarthy MV, Spangenburg EE (2002) Exercise and gene expression: physiological regulation of the human genome through physical activity. J Physiol 543:399-411
30. Terman A, Brunk UT (2004) Myocyte aging and mitochondrial turnover. Exp Gerontol 39:701-705
31. Beregi E, Regius O, Huttl T, Gobi Z (1988) Age related changes in skeletal muscle. Gerontol 21:83-86
32. Suhman HB, Carraway MS, Piantadosi CA (2003) Postlipopolysaccharide oxidative damage of mitochondrial DNA. Am J Respir Crit Care Med 167:570-579
33. Suhman HB, Welty-Wolf KE, Carraway M, Tatro L, Piantadosi CA (2004) Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis. Cardiovasc Res 64:279-288